Caspase inhibitors for liver disease.
Whelan
Jo
J
D017209:Apoptosis / Q000187:drug effects; D061945:Caspase Inhibitors; D017322:Clinical Trials, Phase II as Topic; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy* / Q000201:enzymology
D061945:Caspase Inhibitors; D004791:Enzyme Inhibitors